The subspecialty of pediatric nuclear medicine has rapidly developed since the last discussion1 of the indications for and value of radionuclide imaging in children. New imaging techniques, equipment, and radiopharmaceuticals have stimulated this rapid growth. Bone imaging with the 99mTc phosphate compounds has been applied to evaluate benign as well as malignant processes. Tumor detection and staging have been accomplished with various 99mTc radiopharmaceuticals. Vesicoureteral reflux is more effectively detected with direct radionuclide cystography. A major role in the detection and evaluation of cardiac abnormalities and shunts has been achieved with nuclear techniques.
Recognition of this remarkable growth and development is found in the publication of several books on pediatric nuclear medicine, the presentation of pediatric nuclear in medicine seminars, and formal sessions at the Society of Nuclear Medicine annual meeting.2-6 This brief discussion will hopefully keep the pediatrician aware of the expanding role that radionuclide techniques have in the management of pediatric patients.
- Copyright © 1976 by the American Academy of Pediatrics